	US 11,925,606 B2
	Compositions for managing chronic obstructive pulmonary disease
Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Sarang Bani, Bangalore (IN); and Anjali Pandey, Bangalore (IN)
Assigned to SAMI-SABINSA GROUP LIMITED, Bangalore (IN)
Filed by Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Sarang Bani, Bangalore (IN); and Anjali Pandey, Bangalore (IN)
Filed on Jan. 16, 2021, as Appl. No. 17/151,121.
Claims priority of provisional application 63/126,920, filed on Dec. 17, 2020.
Claims priority of provisional application 62/962,343, filed on Jan. 17, 2020.
Prior Publication US 2021/0220290 A1, Jul. 22, 2021
Int. Cl. A61K 31/12 (2006.01); A61P 11/00 (2006.01)

CPC A61K 31/12 (2013.01) [A61P 11/00 (2018.01)]

12 Claims

1. A method for regeneration of alveolar cells in mammals with emphysema associated with chronic obstructive pulmonary disease, said method comprising step of administering a composition comprising not less than 20% w/w bisdemethoxycurcumin to said mammals to bring about a reduction in features of emphysema.